Value of vWF-related indicators in the diagnosis of liver cirrhosis progression in patients with hepatitis B

Value of vWF-related indicators in the diagnosis of liver cirrhosis progression in patients with hepatitis B

Objective To evaluate the correlation between von Willebrand factor (vWF) and its related indicators and the progression of liver cirrhosis in patients with hepatitis B and explore the diagnostic value of vWF-related indicators in assisting the diagnosis of decompensated liver cirrhosis in patients...

Full description

Saved in:

Bibliographic Details
Main Author:	YANG Mingkang, LIU Yu, XU Guanqun, WANG Jianbiao, WANG Xuefeng, LIANG Qian
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2024-12-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|von willebrand factor\|hepatitis b\|child-pugh liver function score\|decompensated liver cirrhosis
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1740725438504-1141274130.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A comparative analysis between Model for End-stage Liver Disease score (MELD), Modified Model for End-stage Liver Disease score (MELD-Na), and Child–Pugh score (CPS) in predicting complications among cirrhosis patients
by: Anagha Ravinath Naik, et al.
Published: (2025-07-01)

Left Ventricular Diastolic Dysfunction in Liver Cirrhotic Patients: Proportion, Correlation, and Relationship of Diastolic Parameters with Stage of Liver Dysfunction
by: Prionggo Mondrowinduro, et al.
Published: (2018-03-01)

Association of QTc prolongation with liver function test and complications in patients with cirrhosis: An observational study
by: Rhythm Yogandh Relekar, et al.
Published: (2025-06-01)

Study of Serum Zinc Level in Liver Cirrhosis and its Correlation with Stages of Hepatic Encephalopathy
by: Suraj Ramesh Hiwarkar, et al.
Published: (2023-04-01)

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

Evaluation of the effects of the pandemic period on cirrhosis patients
by: Rezan Karaali, et al.
Published: (2023-09-01)

SURGICAL RISK ASSESSMENT IN PATIENTS WITH LIVER CIRRHOSIS – A LITERATURE REVIEW
by: Elina Merashka
Published: (2025-01-01)

Estimating liver cirrhosis severity with extracellular volume fraction by spectral CT
by: Hong Zhang, et al.
Published: (2025-05-01)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023-05-01)

The unwell patient with advanced chronic liver disease: when to use each score?
by: Oliver Moore, et al.
Published: (2025-07-01)

The Psychometric Hepatic Encephalopathy Score for Diagnosis of Minimal Hepatic Encephalopathy in Liver Cirrhosis Patient
by: Cokorde Istri Yuliandari Krisnawardani Kumbara, et al.
Published: (2024-05-01)

Value of colloid hepatic scintigraphy in the evaluation of the condition of patients with hepatic cirrhosis and the functional status of the liver before and after transplantation
by: E. N. Khodareva, et al.
Published: (2018-08-01)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01)

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01)

Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy
by: Yu Chen, et al.
Published: (2025-09-01)

Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study
by: Wasit Wongtrakul, et al.
Published: (2025-02-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Genetic analysis using long-read sequencing to overcome the difficulties in VWF gene
by: Sheng Ye, et al.
Published: (2025-05-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

ИЗМЕНЕНИЯ ОПТИЧЕСКИХ ПАРАМЕТРОВ КРОВИ У ПАЦИЕНТОВ С ЦИРРОЗАМИ ПЕЧЕНИ РАЗЛИЧНОЙ СТЕПЕНИ ТЯЖЕСТИ
by: М. В. Кручинина, et al.
Published: (2014-04-01)

Sarcopenia in chronic liver disease, can we predict complications?
by: U. R. Salimov, et al.
Published: (2022-12-01)

Relationship Between Child Turcotte Pugh (CTP) Score and Esophageal Varices (EV) Among Sudanese Cirrhotic Patients in Wad Madani Teaching Hospital, 2024: A Cross‐Sectional Study
by: Eltype Elsiddig, et al.
Published: (2025-06-01)

Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis
by: Haiyu Wang, et al.
Published: (2025-07-01)

THE RELATION OF SERUM NESFATIN-1 LEVELS WITH DISEASE SEVERITY AND COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS
by: Özlem Kandemir Alibakan, et al.
Published: (2024-07-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE
by: Leticia Macedo EIFLER, et al.
Published: (2024-11-01)

MONOCYTE ADHESION MOLECULES EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND LIVER CIRRHOSIS
by: Nora E.I. El-Bassiouni, et al.
Published: (2013-09-01)

Quantitative assessment of hepatic function by indocyanine green clearance test
by: I. I. Dzidzava, et al.
Published: (2018-08-01)

The Relationship between MELD Score, Bilirubin, Albumin, and INR Levels and Prognosis in Patients with Hepatic Encephalopathy in the Emergency Department
by: Hızır Ufuk Akdemir, et al.
Published: (2025-08-01)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
by: Jung Hee Kim, et al.
Published: (2025-12-01)

RISK STRATIFICATION IN CIRRHOTIC PATIENTS UNDERGOING NONHEPATIC SURGERY –LITERATURE REVIEW
by: E. Merashka
Published: (2025-03-01)

Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child–Pugh Class A Cirrhosis
by: Masanori Fukushima, et al.
Published: (2024-12-01)

Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma
by: Du YQ, et al.
Published: (2025-06-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

The role of salivary caffeine clearance in the diagnosis of chronic liver disease
by: Anurag Tripathi, et al.
Published: (2015-01-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes
by: Joseph C. Ahn, et al.
Published: (2025-05-01)

Effect of Jiawei Fuzi Lizhong decoction on Cys C,T lymphocyte subsets and vWF of patients with acute drug-induced renal damage
by: LAN Fang, et al.
Published: (2017-01-01)

A rational approach to the treatment of hepatic encephalopathy in patients with liver cirrhosis
by: K. V. Zhdanov, et al.
Published: (2014-09-01)